In type 1 diabetes, AI-enabled tools are increasingly used to support nutrition assessment and insulin decision-making, yet their clinical utility and safety remain unclear.<h4>Methods</h4>The study aims to identify and map the evidence on the clinical utility of AI-based diabetes management tools in people with type 1 diabetes. The gene discussed is INS; the disease is type 1 diabetes mellitus.